This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Third View: Discussing the first blood test for diagnosing Alzheimer’s disease, developed by Japan-based Fujirebio Diagnostics.

Ticker(s): FUJIREBIO, LLY, BIIB

Who's the expert?

Institution: Raleigh Neurology Associates 

  • Triple board certified neurologist with sub speciality training in neurophysiology 
  • Medical director at WakeMed Neurodiagnostic Laboratories

Interview Goal
This conversation will focus on the treatment landscape and potential use of blood tests for diagnosing Alzheimer's disease.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.